Details for Patent: 8,299,209

Which drugs does patent 8,299,209 protect, and when does it expire?

Patent 8,299,209 protects SIGNIFOR and is included in one NDA.

This patent has forty-two patent family members in thirty-five countries.

Summary for Patent: 8,299,209

Title:	Pharmaceutical composition comprising cyclic somatostatin analogues
Abstract:	Pharmaceutical compositions comprising a somastatin analogue in the form of a liquid formulation for parenteral administration are disclosed.
Inventor(s):	Lambert; Olivier (Spechbach-le-Haut, FR), Moser; Katrin (Brookline, MA)
Assignee:	Novartis AG (Basel, CH)
Application Number:	12/359,527
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 8,299,209

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Recordati Rare	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-001	Dec 14, 2012		RX	Yes	No			Y	Y
Recordati Rare	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-002	Dec 14, 2012		RX	Yes	No			Y	Y
Recordati Rare	SIGNIFOR	pasireotide diaspartate	SOLUTION;SUBCUTANEOUS	200677-003	Dec 14, 2012		RX	Yes	Yes			Y	Y

Foreign Priority and PCT Information for Patent: 8,299,209

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0314695.8	Jun 24, 2003
United Kingdom	0325388.7	Oct 30, 2004

International Family Members for US Patent 8,299,209

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1648934		PA2012016	Lithuania
European Patent Office	1648934		C20120019 00062	Estonia
European Patent Office	1648934		PA2012016,C1648934	Lithuania
Argentina	044852